Thorough QT/QTc Study of Multiple Oral Doses of NOMAC-E2 (Org 10486 0 + Org 2317) in Healthy Women (Study 292011)(P05802)

NCT00779532 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

189

Enrollment

INDUSTRY

Sponsor class

Conditions

Contraception

Interventions

DRUG: Moxifloxacin
DRUG: NOMAC-E2 (Org 10486-0 + Org 2317)
DRUG: Moxifloxacin placebo
DRUG: NOMAC-E2 placebo

Sponsor

Organon and Co